Heliyon 9 , e20163 (2023)
Phase I randomized, double-blind, placebo-controlled clinical trial investigated intravenous vitamin C in 24 ICU patients with severe sepsis
This article explains what a more complete MCAS natural treatment approach can look like, why personalization matters, and how a root-cause strategy may help patients who feel like conventional symptom management has not gone far enough
Prevention As of early 2025, there are no guideline-recommended pharmacological interventions for prevention of CIPN (Dan 2024
Abstract As cancer therapies advance and patient survival improves, there has been growing concern about the long-term adverse effects that patients may experience following treatment, and concerns have been raised about such persistent, progressive, and often irreversible adverse effects